A history of moderate to severe traumatic brain injury is associated with an increased risk of malignant brain tumors, data suggest.

The FDA is moving to abandon a decades-old policy of asking advisory committees to review drug applications, and critics say the move could shield the agency's decisions from public scrutiny.

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.

It was difficult to determine the effect of bevacizumab on survival in this analysis because details on adjuvant therapy, maintenance therapy, and BRCA or HRD status were not available, the ...

These results support the view that a considerable proportion of cancers arise from stochastic processes, rather than being solely driven by hereditary factors or environmental exposures,” the ...

Adding osimertinib to platinum-based chemotherapy may improve outcomes in patients with EGFR-mutant, advanced NSCLC who had disease progression on first-line osimertinib.

As many as 1 in 5 medical students in the United States may be food-insecure, according to a study published in JAMA Network Open. Researchers surveyed 1834 medical students attending 8 schools ...

Cancer survivors' care can be improved with better coordination between oncologists and primary care providers, experts say.

Adjuvant treatment with NSAIDs can improve disease-free survival and delay recurrence in patients with resected CRC, data suggest.

Peer review and the editorial process yield frequent improvements in research abstracts of randomized clinical trial reports, data suggest.

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular retinoblastoma, according to phase 2 results published in Cancer ...

A report stating that even small amounts of alcohol could raise the risk of cancer and other serious health problems will not be submitted to Congress, according to The New York Times.